Purpose: The aim of this study is to describe "2-paired mini-incisional entropion surgery" for involutional entropion. Methods: This study was a retrospective single-surgeon case series. Patients who underwent different entropion surgeries were reviewed. Patients with involutional entropion were divided into 3 groups according to the type of surgery performed by a single surgeon: 2-paired mini-incisional entropion surgery; transconjunctival retractor reinsertion; or transcutaneous retractor reinsertion. Patients were followed up to 35 months after the surgery. Operation time, complications, and success were compared between groups. Results: Sixty-six lower eyelids of 60 patients were evaluated. The recurrence was 7.7% in the transcutaneous group, was 5.9% in the 2-paired mini-incisional entropion surgery group, and was 5.3% in the transconjunctival group. The total chance of success in 24-month period was 94.7% in the transconjunctival approach group, was 94.1% in the 2-paired mini-incisional entropion surgery group, and was 92.3% in the transcutaneous group. Conclusion: The 2-paired mini-incisional entropion surgery can be used for entropion repair alone or in combination with horizontal tightening surgeries. Accepted for publication November 6, 2020. The authors have no financial or conflicts of interest to disclose. We describe a novel procedure for entropion surgery by comparing 3 surgical procedures performed by a single surgeon. Given the results of the 3 surgical techniques, this surgical procedure may be a useful option for entropion surgery. The author has taken these ethical rules by Sakarya University in 2020. The contents of the article were not presented at a conference. The illustration in the article is the author's own hand drawn. Address correspondence and reprint requests to Ibrahim Ozdemir, MD, Department of Ophthalmology, Yenikent State Hospital, Sakarya 54100, Turkey. E-mail: dr.ibrahimozdemir@gmail.com. © 2021 by The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc., All rights reserved.
No comments:
Post a Comment